rs2228014
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_003467.3(CXCR4):c.414C>T(p.Ile138=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0391 in 1,614,162 control chromosomes in the GnomAD database, including 1,655 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.037 ( 171 hom., cov: 32)
Exomes 𝑓: 0.039 ( 1484 hom. )
Consequence
CXCR4
NM_003467.3 synonymous
NM_003467.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.486
Genes affected
CXCR4 (HGNC:2561): (C-X-C motif chemokine receptor 4) This gene encodes a CXC chemokine receptor specific for stromal cell-derived factor-1. The protein has 7 transmembrane regions and is located on the cell surface. It acts with the CD4 protein to support HIV entry into cells and is also highly expressed in breast cancer cells. Mutations in this gene have been associated with WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
?
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
?
Variant 2-136115514-G-A is Benign according to our data. Variant chr2-136115514-G-A is described in ClinVar as [Benign]. Clinvar id is 259052.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-136115514-G-A is described in Lovd as [Benign].
BP7
?
Synonymous conserved (PhyloP=-0.486 with no splicing effect.
BA1
?
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.115 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CXCR4 | NM_003467.3 | c.414C>T | p.Ile138= | synonymous_variant | 2/2 | ENST00000241393.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CXCR4 | ENST00000241393.4 | c.414C>T | p.Ile138= | synonymous_variant | 2/2 | 1 | NM_003467.3 | P2 |
Frequencies
GnomAD3 genomes ? AF: 0.0368 AC: 5594AN: 152154Hom.: 169 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
5594
AN:
152154
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0457 AC: 11496AN: 251468Hom.: 438 AF XY: 0.0483 AC XY: 6561AN XY: 135914
GnomAD3 exomes
AF:
AC:
11496
AN:
251468
Hom.:
AF XY:
AC XY:
6561
AN XY:
135914
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0394 AC: 57578AN: 1461890Hom.: 1484 Cov.: 32 AF XY: 0.0412 AC XY: 29935AN XY: 727248
GnomAD4 exome
AF:
AC:
57578
AN:
1461890
Hom.:
Cov.:
32
AF XY:
AC XY:
29935
AN XY:
727248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0368 AC: 5597AN: 152272Hom.: 171 Cov.: 32 AF XY: 0.0377 AC XY: 2804AN XY: 74468
GnomAD4 genome
?
AF:
AC:
5597
AN:
152272
Hom.:
Cov.:
32
AF XY:
AC XY:
2804
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
343
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Warts, hypogammaglobulinemia, infections, and myelokathexis Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 06, 2020 | This variant is associated with the following publications: (PMID: 19473177, 31177127) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at